BMEA - Biomea Fusion, Inc.
After hours:
| Previous close | 31.49 |
| Open | 31.39 |
| Bid | 30.70 x 900 |
| Ask | 35.06 x 800 |
| Day's range | 30.55 - 32.56 |
| 52-week range | 4.41 - 36.68 |
| Volume | |
| Avg. volume | 962,729 |
| Market cap | 1.113B |
| Beta (5Y monthly) | -1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.09 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 42.14 |
Simply Wall St.individual investors who own 31% along with institutions invested in Biomea Fusion, Inc. (NASDAQ:BMEA) saw increase in their holdings value last week
Key Insights The considerable ownership by individual investors in Biomea Fusion indicates that they collectively have...
Motley FoolWhy Biomea Fusion Stock Crushed It This Week
A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.
ZacksBiomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study
Preliminary data from an ongoing mid-stage study shows that treatment with Biomea's (BMEA) lead candidate demonstrated a robust glucose-lowering response in patients with type II diabetes.
ZacksBiotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback
Pipelines updates from Viking Therapeutics (VKTX) and Intra-Cellular (ITCI) are the key highlights for the biotech sector.
ZacksHas Aspira Women's Health (AWH) Outpaced Other Medical Stocks This Year?
Here is how Aspira (AWH) and Biomea Fusion, Inc. (BMEA) have performed compared to their sector so far this year.
ZacksWhat Makes Biomea Fusion, Inc. (BMEA) a Good Fit for 'Trend Investing'
Biomea Fusion, Inc. (BMEA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Motley FoolWhy Shares of Biomea Fusion Jumped This Week
What happened Shares of Biomea Fusion (NASDAQ: BMEA) were up 24.1% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence. The biotech company's stock closed at $7.
ZacksBiomea (BMEA) Begins Dosing in Lung Cancer Study, Stock Up
Biomea Fusion (BMEA) announces the successful dosing of the first patient in phase I/Ib study of BMF-219 in KRAS mutant solid tumors. Stocks rise 11.69% in response.
- Simply Wall St.
Here's Why We're Watching Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Simply Wall St.
Institutional owners may take dramatic actions as Biomea Fusion, Inc.'s (NASDAQ:BMEA) recent 29% drop adds to one-year losses
A look at the shareholders of Biomea Fusion, Inc. ( NASDAQ:BMEA ) can tell us which group is most powerful. With 41...
- Simply Wall St.
Despite Biomea Fusion, Inc.'s recent decline, insiders have made a around US$30k profit after buying earlier this year.
Insiders who purchased Biomea Fusion, Inc. ( NASDAQ:BMEA ) shares in the past 12 months are unlikely to be deeply...
- Simply Wall St.
Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Simply Wall St.
How Much Of Biomea Fusion, Inc. (NASDAQ:BMEA) Do Institutions Own?
The big shareholder groups in Biomea Fusion, Inc. ( NASDAQ:BMEA ) have power over the company. Generally speaking, as a...